Details for New Drug Application (NDA): 020088
✉ Email this page to a colleague
The generic ingredient in NORPLANT SYSTEM IN PLASTIC CONTAINER is levonorgestrel. There are twenty drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the levonorgestrel profile page.
Summary for 020088
Tradename: | NORPLANT SYSTEM IN PLASTIC CONTAINER |
Applicant: | Wyeth Pharms Inc |
Ingredient: | levonorgestrel |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 020088
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | IMPLANT;IMPLANTATION | Strength | 36MG/IMPLANT | ||||
Approval Date: | Dec 10, 1990 | TE: | RLD: | No |
Expired US Patents for NDA 020088
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Wyeth Pharms Inc | NORPLANT SYSTEM IN PLASTIC CONTAINER | levonorgestrel | IMPLANT;IMPLANTATION | 020088-001 | Dec 10, 1990 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription